Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10000814 ALK and NTRK1 fusion molecules and uses thereof

Patent 10000814 was granted and assigned to Foundation Medicine on June, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Foundation Medicine

Current Assignee

Foundation Medicine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100008140

Patent Inventor Names

Doron Lipson0

Roman Yelensky0

Maureen T. Cronin0

Date of Patent

June 19, 2018

Patent Application Number

142576070

Date Filed

April 21, 2014

Patent Citations Received

‌

US Patent 11230589 Fusion molecules and uses thereof

‌

US Patent 10980804 Methods of treating cholangiocarcinoma

‌

US Patent 11771698 Methods of treating cholangiocarcinoma

‌

US Patent 11578372 NTRK1 fusion molecules and uses thereof

Patent Primary Examiner

‌

My-Chau T. Tran

Patent abstract

Novel ALK and NTRK1 fusion molecules and uses are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10000814 ALK and NTRK1 fusion molecules and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API